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BACKGROUND: Sexual and gender minority individuals face numerous cancer-related inequities, many of which appear to be 
 underreported. However, to the best of the authors’ knowledge, no one has assessed rates of acquisition of sexual orientation and 
gender identity (SOGI) data within community oncology settings. METHODS: Community oncology practices that were part of the 
NCI Community Oncology Research Program (NCORP) network were asked whether they routinely collected SOGI information and 
coded this information in their electronic medical records. The proportion of practice groups reporting routine collection of sexual 
and/or gender minority information was calculated. Potential associations between the collection of SOGI information and practice 
group–level and state-level characteristics (from Gallup poll data) were also provided. RESULTS: Twenty-four percent of the 
responding NCORP practice groups reported routine collection of sexual orientation information, and 10% reported collection of 
gender identity information. Practices located in western regions of the United States, practices in states with higher proportions of 
sexual and gender minority–identifying individuals, and practices with lower proportions of non-Hispanic patients were more likely 
to ask patients about sexual orientation and/or gender identity. CONCLUSIONS: US oncology practices that participate in research 
do not frequently collect SOGI information from patients with cancer. Educational initiatives should inform oncology staff and pro-
viders about the importance of collecting gender identity and sexual orientation information to improve existent disparities faced by 
sexual and gender minority patients. Cancer 2019;125:1313-1318. © 2018 American Cancer Society. 
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INTRODUCTION
More than 10 million adults in the United States identify as sexual and/or gender minorities (SGMs).1 As an umbrella 
term, SGM encompasses a diverse array of sexual orientations and gender identities, including lesbian, gay, bisexual, 
and transgender (LGBT) as well as queer/questioning, intersex, and others. These diverse SGM individuals face cancer- 
related health care disparities, including low rates of cancer screening, high rates of anal cancer, and high rates of cervi-
cal cancer.2-9 SGM individuals also potentially face a large number of cancer-related issues that remain understudied.2 
Cancer outcomes may be compromised by such inequities, with one study finding that lesbian women with breast cancer 
have greater disease-specific mortality.10
Despite such disparities, health care providers do not routinely ask about sexual orientation and gender identity 
(SOGI).11 Only half of primary care providers and few emergency room physicians inquire about sexual orientation.12-14 
With respect to cancer care, one qualitative study of 39 women with breast cancer observed that health care providers 
rarely or never inquired about their sexual minority status.15 Health care providers may not inquire about SOGI because 
of concerns about offending patients.14,16 Yet, although concerned about discrimination, patients appear to be willing 
to discuss their gender identity and/or sexual orientation.14 One study of 291 LGBT individuals found that 79% self- 
disclosed their identity to a cancer health care provider, sometimes as a way to correct heterosexual assumptions.17 In an 
effort to improve collection of SOGI data, a number of health care initiatives have promoted the inclusion of SOGI in-
formation within medical records, from the 2015 meaningful use stage 3 rules, which require certified electronic medical 
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records (EHRs) to have SOGI fields, to the American 
Society of Clinical Oncology’s recent recommendations 
for the inclusion of SGM status on tumor registries.18,19
Interestingly, no prior study has reported nation-
wide rates of routine collection of SOGI information 
from patients with cancer. Furthermore, little is known 
about the oncology practice characteristics associated 
with routine collection of SOGI information. This study 
was designed to determine the reported rate at which 
community oncology clinics and medical centers collect 
SOGI information and to report on the factors associated 
with higher rates of collecting SOGI data.
MATERIALS AND METHODS
Overview
Data for the current study were drawn from the 2017 
NCI Community Oncology Research Program 
(NCORP) Cancer Care Delivery Research (CCDR) 
Landscape Assessment. NCORP is a National Cancer 
Institute (NCI)–funded research infrastructure that sup-
ports community oncology clinics in recruiting patients 
with cancer and survivors to clinical trials nationwide. 
The CCDR effort aims to facilitate research and trials 
that can improve cancer care delivery nationwide. The 
Landscape Assessment asked administrators and research 
staff employed at NCORP clinics about issues relevant to 
health care delivery and to the conduct of clinical trials. 
The current study focused on only a small part of that as-
sessment, namely the part that queried research practices 
about whether they routinely asked patients with cancer 
about SOGI data. This study was deemed exempt from 
institutional review board review because it relied on a 
nonpatient database and was, therefore, not considered 
human subjects research.
Survey Development and Distribution
The NCORP program developed the CCDR Landscape 
Assessment with an iterative process of question solicita-
tion and review. First, the NCORP research bases and 
community oncology practices were invited to submit 
questions for inclusion in the Landscape Assessment. 
Then, a working group led by a coauthor (K.E.W.) and 
consisting of other coauthors (H.N., A.E.K., R.C., L.G., 
and J.M.U.) and the senior author (C.K.) reviewed the 
questions for their relevance to cancer care delivery re-
search. The final set of reviewed questions was presented 
to NCORP research bases and community oncology 
practices, and staff at the practices were trained to collect 
survey data via a series of webinars. The survey was then 
distributed to NCORP practice groups electronically.
An NCORP practice group was defined with 
Cancer Therapy Evaluation Program (CTEP) institu-
tion codes; these codes are intended to represent discrete 
clinical settings in the United States that are available to 
participate in NCI-sponsored research and to organize 
clinical trial data submitted to the NCI. In some cases, 
several clinical locations in the same geographic region 
with different CTEP codes shared oncologists, patients, 
and services (eg, a main hospital and satellite clinics). 
These practices submitted Landscape data together as a 
practice group with multiple CTEP IDs.
Study Goals
The primary goal of the current study was to report the 
percentage of NCORP community oncology practice 
groups that reported on collecting information on patients’ 
SOGI. The secondary goal was to report on the character-
istics of institutions that collected this information.
Measures
The 2 survey questions relevant to SOGI information 
were as follows:
• “Does your component/subcomponent collect and re-
cord information about patients’ sexual orientation in 
the EHR?”
• “Does your component/subcomponent collect and re-
cord information in the EHR about patients’ gender 
identity? This would be distinct from the standard 
male-female sex field.”
Within the Landscape Assessment, the term compo-
nent/subcomponent refers to the specific NCORP com-
munity oncology practice group.
In addition to the aforementioned questions, prac-
tice group–specific information obtained from the sur-
vey and used in our analyses included the following: the 
geographic location of each group; the practice group 
ownership status; the reported proportions of patients 
at the research practice group with insurance coverage 
from Medicaid, insurance coverage from both Medicare 
and Medicaid, charity care, and no insurance; the total 
number of new cancer cases each year; the percentage 
of the practice group’s patient population that identified 
as non-Hispanic; the percentage of the group’s patient 
population that identified as white; and the dedicated 
outreach staff for minority outreach. To benchmark, we 
used Gallup poll data on rates of SGM individuals living 
in each state.20 For the multivariate analyses in this re-
port, only the aforementioned variables and Gallup poll 
data were used.
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Statistical Analyses
Initial univariate evaluations of associations between 
variables were conducted with chi-square and Kruskal 
Wallis tests (significance at P < .05). A logistic regres-
sion model that used backward elimination (with P < .2 
as the staying threshold) further evaluated potential as-
sociations between the reported collection of sexual 
orientation information (yes/no) and gender identity in-
formation (yes/no). The pool of variables that were used 
during backward selection included the following: prac-
tice group region (categorical), new cases per year, type 
of ownership, Medicaid insurance proportion, Medicare 
insurance proportion, uninsured insurance proportion, 
dual Medicare-Medicaid insurance proportion, charity 
care insurance proportion, percent non-Hispanic, per-
cent white, and statewide percent LGBT.
RESULTS
Practice Group Characteristics
A total of 943 CTEP institution codes were registered 
as part of the NCORP network in 2017. Information 
for 504 of these CTEP institution codes was provided 
as part of the Landscape Assessment. Survey respond-
ents clustered these 504 codes into 227 distinct practice 
groups. Respondents indicated that these practice groups 
shared providers, patients, and infrastructure and gener-
ally had a common electronic health record; thus, prac-
tice-level responses should apply to the practice group 
as a whole. Based on the estimate of available data for 
504 of the total of 943 CTEP codes, the response rate 
to the survey as a whole was 53%. Of the sample of 227 
practice groups that responded to any part of the survey, 
221 responded to the question on the collection of sexual 
orientation data, and 222 responded to the question on 
the collection of gender identity information.
Survey Results
Of the 221 practice groups that responded to both 
SOGI questions, 14 practice groups (6.3%) collected 
both gender identity and sexual orientation information. 
Thirty-nine practice groups (17.6%) collected only sex-
ual orientation information. Nine practice groups (4.1%) 
collected only gender identity information. One hundred 
fifty-nine practice groups (71.9%) collected neither gen-
der identity nor sexual orientation information.
Fifty-three community oncology practice groups 
(24% of those that completed the survey) reported that 
they routinely collected information on sexual orienta-
tion. Table 1 shows statistically significant associations 
between the collection of sexual orientation information 
and practice group characteristics. Notably, although ini-
tial univariate analyses showed an association between 
dedicated staff for minority outreach and routine collec-
tion of sexual orientation information (Kruskal-Wallis 
P = .04), this association was not observed in the mul-
tivariate model.
Twenty-three practice groups (10%) reported that 
they routinely collected information on patient gender 
identity. Table 2 and Figure 1 show statistically signifi-
cant associations between the collection of gender iden-
tity information and practice group characteristics. On 
the basis of the multivariate logistic regression analyses, 
we observed that sites in the western region of the United 
States were more likely to collect gender identity informa-
tion than sites in the southern (P = .0092) and midwest-
ern regions (P = .0092). Practice groups that identified 
as a hospital, clinic, or physician practice owned by a 





Collection of Sexual 
Orientation Information 
Reported to Occur
Collection of Sexual 
Orientation Information 

















Yes 15 (34.9) 28 (65.1) .04 Not included in multivariate analysesc
No 36 (20.5) 140 (79.5)
Abbreviation: SGM, sexual and/or gender minority.
aFor categorical variables, numbers and percentages (in parentheses) as well as chi-square P values are reported. For continuous variables, means and stand-
ard deviations as well Kruskal-Wallis P values are reported.
bNineteen of the 221 practice groups that responded to the sexual orientation question were excluded from multivariate analyses because of missing data.
cRemoved from the model on the basis of backward elimination.
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large regional/multistate health system were less likely 
to report collecting gender identity information than 
both independently owned sites (P = .0260) and practice 
groups within another category of ownership (P = .0379) 
according to the multivariate model. Likewise, groups for 
which more than 10% of the patients had both Medicare 
and Medicaid were less likely to routinely collect gender 
identity information according to the multivariate model 
(P = .0187). Conversely, although the initial univariate 
analyses showed an association between the percentage of 
the state population identifying as SGM and the routine 
collection of gender identity information (Kruskal-Wallis 
P = .0295), this association was not observed in multi-
variate analyses.
DISCUSSION
Only approximately 1 in 5 responding NCORP com-
munity oncology practice groups reported routinely 
collecting SOGI data, and site characteristics, including 
the location of the practice group, whether the group 
served a lower proportion of non-Hispanic patients, and 
whether the group served a higher proportions of LGBT-
identifying individuals, were all directly associated with 
a greater likelihood of querying patients about such in-
formation. In keeping with the growing literature on 
underreporting,11-15 this study shows that even in a large 
NCI-funded research network, health care providers and 











Reported to Not 
Occur P Odds Ratio
Confidence 
Interval P
Practice group region Midwestern 7 (6.3) 104 (93.7) .03 1 Reference .02
Western 10 (21.7) 36 (78.3) 3.01 1.31-6.88
Northeastern 2 (14.3) 12 (85.7) 1.23 0.34-4.49
Southern 4 (7.8) 47 (92.2) 0.44 0.16-1.23
Practice ownership type Independently owned 9 (11.4) 70 (88.6) .07 1 Reference .08
Hospital, clinic, or 
physician practice 
owned by a large 
regional/multistate 
health system
9 (7.5) 111 (92.5) 0.45 0.22-0.91
Other 5 (23.8) 16 (76.2) 1.90 0.83-4.35
Non-Hispanic ethnicity, % Not available 80.3 ± 23.9 88.5 ± 24.5 .05 0.69 (per 24.84% 
increase)
0.44-1.07 .09
Proportion of dual 
Medicare-Medicaid 
cases
≤10% 20 (13.2) 131 (86.8) .10 1 Reference .02
>10% 3 (5.3) 54 (94.7) 0.43 0.21-0.89
State population 
identifying as SGMs, %
Not available 4.1 ± 0.6 3.8 ± 0.5 .03 Not included in multivariate analysesc
Abbreviation: SGM, sexual and/or gender minority.
aFor categorical variables, numbers and percentages (in parentheses) as well as chi-square P values are reported. For continuous variables, means and stand-
ard deviations as well Kruskal-Wallis P values are reported.
bTwenty-two of the 222 practice groups that responded to the gender identity question were excluded from multivariate analyses because of missing data.
cRemoved from the model on the basis of backward elimination.
Figure 1. Practice group characteristics statistically signifi-
cantly associated with reporting gender identity.
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health care personnel remain reluctant to ask for SOGI 
information. Because data collection on SOGI status does 
not occur at the majority of cancer institutions, SGM pa-
tients cannot be identified and may be underserved when 
they are cared for at cancer clinics. Physicians who are 
unaware that they are treating SGM patients may be less 
responsive to these patients’ needs, and this may contrib-
ute to a lack of patient-centered care.
Not surprisingly, states in the United States with 
a higher proportion of SGM patients and with nondis-
crimination legislation appear to have higher rates of 
asking about gender identity information. For instance, 
California, Oregon, and Washington have statewide em-
ployment, antibullying, and public accommodation leg-
islation, have higher percentages of SGM individuals, and 
are more likely to collect SOGI information.21 Although 
the association was not evaluated directly in this study, 
we surmise that SGM individuals who live in regions that 
harbor SGM-friendly attitudes might explain this favor-
able association because such states likely have higher 
numbers of SGM-friendly staff and thereby provide an 
SGM-welcoming environment.22 Educating oncology 
staff on cultural sensitivity toward SGM individuals and 
hiring staff of all sexual orientations and gender identities 
may enhance collection of SOGI information.
Interestingly, this study also showed that commu-
nity oncology practice groups with more ethnic diversity 
(measured by proportions of non-Hispanic patients) were 
more likely to ask about sexual orientation. Although it 
is not clear why this relation was observed, SGM indi-
viduals are more likely to lack adequate insurance and 
to report unmet medical needs, and this sometimes 
makes them recipients of care in underserved areas.23 
Potentially, the health care providers who work in these 
underserved clinics are more adept at managing a variety 
of issues among various minority groups and are hence 
willing to ask about SOGI information. This may also 
be a result of the higher proportion of Hispanic patients 
seen in the Western United States.
This study has both strengths and weaknesses. A 
strength is that this work was undertaken nationwide 
within research settings embedded in community-based 
oncology settings. Although previous studies on this topic 
have focused on clinical practice settings, this research 
perspective is of great importance.13,17 Understanding 
that SGM issues are not addressed in a research setting 
undercuts our ability to learn how to better screen or de-
tect cancer in potentially high-risk SGM individuals and 
to learn whether malignancies within SGM individuals 
behave differently and, therefore, require a modified 
treatment approach. Thus, at a broad public health 
level, these findings point to a need for further educa-
tion among health care providers and clinical research 
personnel in an effort to collect these data routinely and 
systematically. In terms of weaknesses, this study did 
not use a validated questionnaire to assess SOGI data. 
The fact that our survey was rooted in a quality initia-
tive and the fact that our queries and goals are somewhat 
unique explain why our project needed to be built from 
the ground level. In addition, response rates were low, 
and this increased the risk for a nonresponse bias. For 
this reason as well, the power to detect true associations 
may have been limited. Similarly, we are unable to report 
on data from practice groups that did not provide a re-
sponse because no comparable data are available for these 
groups. Despite such limitations, this study provides im-
portant information that should prompt efforts to better 
serve this understudied minority population.
In summary, this study provides an important start-
ing point for investigating the integration of SOGI in-
formation into cancer clinical trial research. Such efforts 
will be of value in moving forward research initiatives and 
better patient care in this group of patients with cancer.
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